Results 101 to 110 of about 104,601 (291)

Multicentric lymphomas in goats (Capra hircus): Clinical manifestations, therapeutic modalities and pathological characteristics

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract Two cases of sporadic multicentric lymphomas with mediastinal masses in goats are documented. The first case involved a 3.5‐year‐old male goat. Ultrasound imaging revealed an enlarged right perirenal lymph node, which was confirmed as lymphoma through incisional biopsy and cytopathological analysis. Despite treatment, the goat succumbed to the
Angélica Consalter   +6 more
wiley   +1 more source

Pediatric patient with peritoneal mesothelioma harboring ALK rearrangement

open access: yesCurrent Problems in Cancer: Case Reports, 2021
Malignant mesothelioma is a rare disease that typically occurs in older patients with prolonged exposure to asbestos. The majority of mesothelioma occurs in the pleura.
Reema A Patel, MD   +10 more
doaj  

Peritoneal mesothelioma

open access: yesBritish Journal of Hospital Medicine, 2010
A 59-year-old building surveyor presented with a 2-month history of lethargy and abdominal swelling. There was no associated abdominal pain, change in bowel habit or jaundice. There was no significant past medical history. His alcohol intake was approximately 60 units per week.
James, Berrill   +2 more
openaire   +4 more sources

Persistent pleural effusion secondary to sarcomatosis in a dog

open access: yesVeterinary Record Case Reports, EarlyView.
Abstract A 6‐year‐old, neutered, male German shepherd dog presented to the Emergency and Critical Care Service at the Ohio State University Veterinary Medical Center with bilateral pleural effusion. Thoracic computed tomography, among other diagnostics, failed to identify the cause of the pleural effusion.
Daniel N. Feinbloom   +2 more
wiley   +1 more source

Hippo pathway effectors are associated with glioma patient survival, control cell proliferation and sterol metabolism through TEAD3

open access: yesBrain Pathology, EarlyView.
The Hippo pathway transcription factor TEAD3 represents an independent prognostic biomarker of tumor recurrence and a potential therapeutic vulnerability through its regulation of cholesterol metabolism in glioma. Abstract Glioblastomas represent the most common and lethal primary brain tumors in the world.
Konstantin Masliantsev   +10 more
wiley   +1 more source

A case of ovarian mesothelioma with VHL mutation diagnosed by immunohistochemistry and literature review

open access: yesFrontiers in Oncology
The malignant mesothelioma mainly develops in the pleura and peritoneum, while primary ovarian mesothelioma is very rare. Here, we report the first case of primary ovarian mesothelioma (clear cell variant) with VHL mutations in the world based on the ...
Ye Yao, Hao Yan, Jing Xiong, Yaqi Duan
doaj   +1 more source

The impact of Foxp3+ regulatory T‐cells on CD8+ T‐cell dysfunction in tumour microenvironments and responses to immune checkpoint inhibitors

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitors (ICIs) have been a breakthrough in cancer therapy, inducing durable remissions in responding patients. However, they are associated with variable outcomes, spanning from disease hyperprogression to complete responses with the onset of immune‐related adverse events.
Mikhaël Attias, Ciriaco A. Piccirillo
wiley   +1 more source

Pleuropericardial mesotheliomas: A report of two unusual cases

open access: yesAsian Journal of Oncology, 2018
Mesothelioma is an aggressive malignant tumor of the mesothelium. The majority of mesotheliomas arise from the pleura. However, less commonly mesothelioma can arise in other locations such as peritoneal, pericardium, or tunica vaginalis testis. We report
Harsha Vardhana Kuruba Ramanjaneyulu   +3 more
doaj   +1 more source

KEYNOTE‐A17: First‐Line Pembrolizumab Plus Cisplatin–Pemetrexed in Japanese Participants With Advanced Pleural Mesothelioma

open access: yesCancer Science, EarlyView.
In the phase 1b KEYNOTE‐A17 study of first‐line pembrolizumab plus chemotherapy in Japanese participants with advanced pleural mesothelioma (PM), 2 of 18 participants (11%) evaluated experienced dose‐limiting toxicities. The objective response rate among all 19 participants in the study was 74%, with 14 participants achieving a partial response and a ...
Takashi Kijima   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy